Alcon is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. The 15-day window averages about 0.9 stories each week. At 5, the average consequence score sits below the same-window beat average of 6.1. They are better corroborated than the beat average, carrying 3 original sources each against 2.7 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about CooperCompanies
Alcon is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. The 15-day window averages about 0.9 stories each week. At 5, the average consequence score sits below the same-window beat average of 6.1. They are better corroborated than the beat average, carrying 3 original sources each against 2.7 for the same window. earnings accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. CooperCompanies appears in 2 tracked Finance stories published from February 19, 2026 through March 5, 2026.
Stories tracked
2
Per week
0.9
Sources per story
3
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 1085 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering CooperCompanies. Shared-story counts are live from our verified record — not editorial picks.
CooperCompanies and Rumble both reported fourth-quarter 2025 financial results that met analyst expectations, signaling operational stability in the medical device and digital media sectors. While both firms navigated macroeconomic headwinds, their ability to hit consensus targets provides a floor for investor sentiment heading into the 2026 fiscal year.
Analyst sentiment remains a critical barometer for Principal Financial, Raymond James, Cooper Companies, and Elevance Health as they navigate sector-specific headwinds. While wealth management and retirement services show resilience, the healthcare and medical device sectors face evolving regulatory and utilization challenges.